Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
4,581.10
+24.10 (0.53%)
Oct 29, 2026, 12:40 PM IST
Torrent Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 28 analysts polled by S&P Global, Torrent Pharmaceuticals stock has a consensus rating of "Buy" and an average price target of ₹5,473. The average 1-year stock price forecast is 19.46% higher than the current stock price, while the lowest is ₹4,545 (-0.79%) and the highest is ₹6,478 (+41.41%).
Price Target: ₹5,473 (+19.46%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Torrent Pharmaceuticals stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 16 | 16 | 16 | 16 | 15 | 16 |
| Buy | 6 | 6 | 7 | 7 | 7 | 7 |
| Hold | 5 | 6 | 5 | 5 | 5 | 4 |
| Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 28 | 29 | 29 | 29 | 28 | 28 |
Financial Forecast
Revenue This Year
199.65B
from 139.80B
Increased by 42.82%
Revenue Next Year
224.38B
from 199.65B
Increased by 12.38%
EPS This Year
64.06
from 65.88
Decreased by -2.76%
EPS Next Year
90.90
from 64.06
Increased by 41.89%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.